OBJECTIVES: Monitoring and evaluation of national antiretroviral therapy (ART) programs is vital, but routine, standardized assessment of national ART patient monitoring systems has not been established. Malawi has undertaken an ambitious ART scale-up effort, with over 57,000 patients initiated on ART by June 2006. We assessed the national ART monitoring and evaluation system in Malawi to ensure that the response to the epidemic was being monitored efficiently and effectively, and that data collected were useful. METHODS: The evaluation, performed in August 2005, generally followed the Updated Guidelines for Evaluating Public Health Surveillance Systems (CDC) and Interim Patient Monitoring Guidelines for HIV Care and ART (WHO). Assessment was conducted with qualitative methods, including twelve ART site visits, with standardized key informant interviews with ART clinic coordinators, clinical staff, and data managers, at each site. Meetings were also held with key governmental stakeholders, including Ministry of Health and National AIDS Commission. RESULTS: The national monitoring and evaluation system devised by the Ministry of Health HIV/AIDS Unit is successful in achieving its objectives, and facilitates important aspects of the national response to HIV. Several basic changes in the data collection tools and system would facilitate more effective long-term assessment of the ART program and support improved patient care. As the number of ART sites and patients continues to expand, the current manual paper-based system may be overwhelmed. Identification and implementation of a feasible electronic data system that would maintain and improve data quality and the efficiency of data recording and reporting and enhance patient care is a priority. CONCLUSIONS: The assessment of ART monitoring and evaluation systems can optimize the effectiveness of national ART programs, and should be considered in other resource-constrained countries rapidly scaling up ART.
OBJECTIVES: Monitoring and evaluation of national antiretroviral therapy (ART) programs is vital, but routine, standardized assessment of national ART patient monitoring systems has not been established. Malawi has undertaken an ambitious ART scale-up effort, with over 57,000 patients initiated on ART by June 2006. We assessed the national ART monitoring and evaluation system in Malawi to ensure that the response to the epidemic was being monitored efficiently and effectively, and that data collected were useful. METHODS: The evaluation, performed in August 2005, generally followed the Updated Guidelines for Evaluating Public Health Surveillance Systems (CDC) and Interim Patient Monitoring Guidelines for HIV Care and ART (WHO). Assessment was conducted with qualitative methods, including twelve ART site visits, with standardized key informant interviews with ART clinic coordinators, clinical staff, and data managers, at each site. Meetings were also held with key governmental stakeholders, including Ministry of Health and National AIDS Commission. RESULTS: The national monitoring and evaluation system devised by the Ministry of Health HIV/AIDS Unit is successful in achieving its objectives, and facilitates important aspects of the national response to HIV. Several basic changes in the data collection tools and system would facilitate more effective long-term assessment of the ART program and support improved patient care. As the number of ART sites and patients continues to expand, the current manual paper-based system may be overwhelmed. Identification and implementation of a feasible electronic data system that would maintain and improve data quality and the efficiency of data recording and reporting and enhance patient care is a priority. CONCLUSIONS: The assessment of ART monitoring and evaluation systems can optimize the effectiveness of national ART programs, and should be considered in other resource-constrained countries rapidly scaling up ART.
Authors: Bradley C Fetzer; Mina C Hosseinipour; Portia Kamthuzi; Lisa Hyde; Brian Bramson; Kebba Jobarteh; Kristine Torjesen; William C Miller; Irving Hoffman; Peter Kazembe; Charles Mwansambo Journal: Trop Med Int Health Date: 2009-06-28 Impact factor: 2.622
Authors: Maria E Garcia; Michelle S Li; Hellen Siril; Claudia Hawkins; Sylvia Kaaya; Shabbir Ismail; Guerino Chalamilla; Sarah Geoffrey Mdingi; Lisa R Hirschhorn Journal: Int J Qual Health Care Date: 2011-03-26 Impact factor: 2.038
Authors: Maureen Braun; Mark M Kabue; Eric D McCollum; Saeed Ahmed; Maria Kim; Leela Aertker; Marko Chirwa; Michael Eliya; Innocent Mofolo; Irving Hoffman; Peter N Kazembe; Charles van der Horst; Mark W Kline; Mina C Hosseinipour Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Ralf Weigel; Janne Estill; Matthias Egger; Anthony D Harries; Simon Makombe; Hannock Tweya; Andreas Jahn; Olivia Keiser Journal: AIDS Date: 2012-01-28 Impact factor: 4.177
Authors: Mathieu Forster; Christopher Bailey; Martin W G Brinkhof; Claire Graber; Andrew Boulle; Mark Spohr; Eric Balestre; Margaret May; Olivia Keiser; Andreas Jahn; Matthias Egger Journal: Bull World Health Organ Date: 2008-12 Impact factor: 9.408
Authors: Troy D Moon; Janeen R Burlison; Mohsin Sidat; Paulo Pires; Wilson Silva; Manuel Solis; Michele Rocha; Chiqui Arregui; Eric J Manders; Alfredo E Vergara; Sten H Vermund Journal: Retrovirology (Auckl) Date: 2010-04-23
Authors: Simon D Makombe; Mindy Hochgesang; Andreas Jahn; Hannock Tweya; Bethany Hedt; Stuart Chuka; Joseph Kwong-Leung Yu; John Aberle-Grasse; Olesi Pasulani; Christopher Bailey; Kelita Kamoto; Erik J Schouten; Anthony D Harries Journal: Bull World Health Organ Date: 2008-04 Impact factor: 9.408
Authors: Geoffrey A Preidis; Eric D McCollum; William Kamiyango; Alejandro Garbino; Mina C Hosseinipour; Peter N Kazembe; Gordon E Schutze; Mark W Kline Journal: J Acquir Immune Defic Syndr Date: 2013-05-01 Impact factor: 3.731